Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONWARDS 6: once-weekly insulin icodec versus once-daily insulin degludec in adults with type 1 diabetes
jRCT2031210031Completed
- Sponsor
- Novo Nordisk
- Start
- Apr 2021
- Modality
- Recombinant Proteins and Enzymes, Peptides
01
Overview
Randomised trial in diabetes mellitus type 1 (T1D) comparing Once-weekly insulin icodec + insulin aspart with Once-daily insulin degludec + insulin aspart (2 arms). Started Apr 2021; status: completed.
02
Drugs
insulin icodecinsulin degludecinsulin aspart
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on jRCT2031210031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210031.